Perspectives

Life Sciences Connect

Our podcast series on the Life Sciences Industry

Life Sciences Connect explores the big issues, the emerging trends and the cutting edge innovations that are shaping the Life Sciences Industry. Each month, we will connect with industry experts and leaders from the Biotech, Pharmaceutical and Medical Devices industries to discuss how key trends, explored in our research reports, are charting a new, sustainable future for the Life Sciences Industry.

Episode #19: Advancing health equity to build a healthier more inclusive world
Episode 19 of the Life Sciences Connect podcast sheds light on the important topic of Health equity and dives into discussions around what this really means, what businesses can do to improve this, how diversity groups are affected and much more. To learn more about health equity and other important issues facing public health in the UK, explore out Future of Public Health Series

Listen now
Episode #18: Hospital Activation
Listen to episode eighteen of the Life Sciences Connect podcast where we talk to specialists about Hospital Activation, how we are breaking from the traditional approach and what the future holds.

Listen now
Episode #17: Evaluating the role of employers in reducing the public health gap: Improving the health and productivity of employees
Listen to episode seventeen of the Life Sciences Connect podcast here where we continue with the Future of Public Health series and dive further into the report- Evaluating the role of employers in reducing the public health gap: Improving the health and productivity of employees.

Listen now
Episode #16: Negating the public health gap with Dr Karen Kirkham and Sara Siegel
In episode sixteen of the Life Sciences Connect podcast, we delve into the details of the fourth report in our Future of Public Health series. Negating the gap - Preventing ill health and promoting healthy behaviours, explores the complexities of public health prevention and the challenges associated with of improving prevention and reducing health inequalities.

Listen now
Episode #15: Nurturing growth: Measuring the return from pharmaceutical innovation 2021
In episode fifteen of the Life Sciences Connect podcast, we dive into the conversation around our annual R&D Measuring the return from pharmaceutical innovation series report.This report analyses the projected return on investment that biopharma companies can expect to earn from their late-stage pipelines.

Listen now
Episode #14: Post COP-26, our hopes for a healthier future
In episode fourteen of the Life Sciences Connect podcast, we dive into the conversation around planetary health and the interrelationships between climate change and healthcare. Following COP26, our hopes for a healthier future by tackling healthcare’s impact on climate change as well as the impact of climate change on people’s health.

Listen now
Episode #13: Narrowing the gap: A fairer and more sustainable future for public health
In our thirteenth episode of the Life Sciences Connect podcast series, we discuss the findings from The Future of Public Health Series, covered in the overview report: Narrowing the gap: A fairer and more sustainable future for public health. This first instalment of the series summarises the key takeaways from our research of the challenges pre-pandemic, the impact of COVID-19 and the implications for the future for public health systems in the UK.

Listen now
Episode #12: Trust in the Pharma Industry
In our twelfth episode of the Life Sciences Connect podcast series, we discuss the public perception of trust in the pharma industry. We discuss the results from the research report Overcoming biopharma’s trust deficit: Why people mistrust the biopharma industry as well as discussing how COVID-19 has affected these perceptions and how the industry might improve diversity of clinical trials by improving trust.

Listen now
Episode #11: How can AI play a critical role in the Biopharma commercial model?
Our eleventh episode of the Life Sciences Connect series explores the critical role AI plays in Biopharma launch and commercial activities.

Listen now
Episode #10: Seeds of change for pharma R&D returns
Our tenth episode of Life Sciences Connect series explores our latest insights on pharma R&D productivity including the impact and learnings from the pandemic.

Listen now
Episode #9: What is driving MedTech’s transformation?
Our ninth episode of Life Sciences Connect series explores the key trends for the MedTech industry including the rise in consumer organisations entering the space, the evolution from product to service, the changing regulatory landscape, and the acceleration of MedTech in healthcare because of COVID-19.

Listen now
Episode #8: James Gregson on trends transforming life sciences and healthcare
In our eighth episode of Life Sciences Connect, we talk to Deloitte’s new Life Sciences and Healthcare leader James Gregson on what he hopes to accomplish in his new role, tips for managing work and family life along with his views on the trends transforming the industry.

Listen now
Episode #7: The future unmasked - Predicting the future of healthcare and life sciences in 2025
In the seventh episode of Life Sciences Connect, we discuss what the future holds for Life Sciences and Healthcare in 2025.

Listen now
Episode #6: Real World Evidence
Our sixth podcast looks at the impact Real World Evidence has on biopharma companies, how best to implement knowledge management systems to maximise Real World Data (RWD), the importance of change management and the role skills and talent has in maximising value from RWD.

Listen now
Episode #5: Digital transformation in healthcare
Our fifth podcast looks at the key issue of digital transformation of the healthcare systems across Europe, and the impact COVID-19 has had on accelerating progress. We discuss the findings of our report, Shaping the future of European healthcare, and get insights from those already providing digital healthcare services.

Listen now
Episode #4: Scaling Biotech companies in challenging times
The Biotech sector is a key player in driving biopharma innovation and developing ground-breaking treatments for patients. Supporting the growth of this sector is vital to ensure that R&D efforts continue, both now and in the future. However, like most industries, this sector faces a complex set of challenges. In the fourth episode of Life Sciences Connect, we explore these challenges and the opportunities facing the Biotech Industry.

Listen now
Episode #3: Transforming Drug Supply Chains
The COVID-19 pandemic has brought unprecedented challenges, highlighting the limitations of traditional linear supply chains and acting as a catalyst for the acceleration of digital transformation. In the third episode of Life Sciences Connect, we explore digital transformation of biopharma supply chains and adoption of artificial intelligence.

Listen now
Episode #2: The Future of Health
In the second episode of Life Sciences Connect, we explore how the COVID-19 pandemic has accelerated the move towards the Future of Health, where technology and data enable health care that is more personalised, predictive, preventative and participatory.

Listen now
Episode #1: Artificial Intelligence in Clinical Trials
For our first episode, we explore the use of Artificial Intelligence in clinical trials and how regulators are embracing new technologies. The current COVID-19 pandemic has caused widespread disruption to ongoing clinical trials. In response, regulatory bodies have issued patient safety-focused guidance advising sponsors to employ a risk-based approach to implementing COVID-19 contingency plans.

Listen now

Did you find this useful?